Skip to Content
MilliporeSigma
All Photos(3)

Documents

SAB4504190

Sigma-Aldrich

Anti-phospho-HDAC6 (pSer22) antibody produced in rabbit

affinity isolated antibody

Synonym(s):

Anti-CPBHM, Anti-HD6, Anti-JM21, Anti-PPP1R90

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352203
NACRES:
NA.41

biological source

rabbit

Quality Level

conjugate

unconjugated

antibody form

affinity isolated antibody

antibody product type

primary antibodies

clone

polyclonal

form

buffered aqueous solution

mol wt

antigen 131 kDa

species reactivity

human, rat, mouse

concentration

~1 mg/mL

technique(s)

ELISA: 1:1000
immunofluorescence: 1:100-1:500
immunohistochemistry: 1:50-1:100
western blot: 1:500-1:1000

NCBI accession no.

UniProt accession no.

shipped in

wet ice

storage temp.

−20°C

target post-translational modification

phosphorylation (pSer22)

Gene Information

human ... HDAC6(10013)

General description

Histone deacetylases 6 (HDAC6) is encoded by the gene mapped to human chromosome Xp11.23. It belongs to the class IIb histone deacetylase family of enzymes, that remove acetyl groups from lysine residues. This protein is present mainly in cytosol.

Immunogen

The antiserum was produced against synthesized peptide derived from human HDAC6 around the phosphorylation site of Ser22.

Immunogen Range: 7-56

Biochem/physiol Actions

Histone deacetylases 6 (HDAC6) is associated with various cellular processes such as regulation of microtubules, growth factor-induced chemotaxis, misfolded protein stress response, and tumor invasion. Increased expression of HDAC6 might promote tumorigenesis by upregulating the expression of c-myc. Overexpression of HDAC6 is seen in acute myeloid leukemia and some breast cancer patients. Oncogenic K-ras imparts suberoylanilide hydroxamic acid (SAHA) resistance via increasing HDAC6 and c-myc expression. HDAC6 controls cellular protective response against cytotoxic accumulation of toxic bioproducts. HDAC6 Inhibition is considered to be a potential therapeutic strategy for treating inflammatory breast cancer (IBC) patients. HDAC6 and acetylated α-tubulin play a vital role in regulation of adipocyte differentiation.

Features and Benefits

Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.

Physical form

Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Preeti Putcha et al.
Breast cancer research : BCR, 17(1), 149-149 (2015-12-09)
Inflammatory breast cancer (IBC) is the most lethal form of breast cancers with a 5-year survival rate of only 40 %. Despite its lethality, IBC remains poorly understood which has greatly limited its therapeutic management. We thus decided to utilize an
Nicolas Forcioli-Conti et al.
Biochimie, 124, 112-123 (2015-09-13)
The primary cilium is an organelle present in most of the cells of the organism. Ciliopathies, such as the Bardet Biedl and the Alstrom syndromes are associated with obesity. We, and others, have shown that the primary cilium undergoes size
Assignment of the human histone deacetylase 6 gene (HDAC6) to X chromosome p11.23 by in situ hybridization.
U Mahlknecht et al.
Cytogenetics and cell genetics, 93(1-2), 135-136 (2001-07-28)
Qun Wang et al.
Oncotarget, 7(9), 10064-10072 (2016-02-06)
Histone deacetylase inhibitors (HDIs) represent a new class of anticancer drugs. Suberoylanilide hydroxamic acid (SAHA), the first HDI approved for the treatment of cutaneous T cell lymphoma (CTCL), is currently being tested in clinical trials for other cancers. However, SAHA

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service